GS-13-Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection

2019 ◽  
Vol 70 (1) ◽  
pp. e81 ◽  
Author(s):  
Heiner Wedemeyer ◽  
Katrin Schöneweis ◽  
Pavel O. Bogomolov ◽  
Natalia Voronkova ◽  
Vladimir Chulanov ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Interferon Alpha ◽  
Phase 2 ◽  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Phase ◽  
Phase 2 Clinical Trial ◽  
Chronic Hbv

scholarly journals 988 An open-label phase 2 clinical trial of topical remetinostat gel for basal cell carcinoma

2019 ◽  
Vol 139 (5) ◽  
pp. S171
Author(s):  
N. Urman ◽  
S. Eichstadt ◽  
H. Do ◽  
A.N. Mirza ◽  
S. Li ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Phase 2 ◽  
Open Label ◽  
Open Label Phase ◽  
Phase 2 Clinical Trial

Apatinib for advanced osteosarcoma after failure of standard multimodal therapy: An open label phase 2 clinical trial.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 11520-11520 ◽  
Author(s):  
Lu Xie ◽  
Jie Xu ◽  
Xin Sun ◽  
Xiaodong Tang ◽  
Taiqiang Yan ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Multimodal Therapy ◽  
Phase 2 ◽  
Open Label ◽  
Open Label Phase ◽  
Phase 2 Clinical Trial

scholarly journals Safety and efficacy of MIM D3 ophthalmic solutions in a randomized placebo controlled Phase 2 clinical trial in patients with dry eye

2013 ◽  
pp. 1275 ◽  
Author(s):  
Karen Meerovitch ◽  
Gail Torkildsen ◽  
John Lonsdale ◽  
Heidi Goldfarb ◽  
Teresa Lama ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Dry Eye ◽  
Phase 2 ◽  
Safety And Efficacy ◽  
Phase 2 Clinical Trial ◽  
Ophthalmic Solutions
Sign in / Sign up

Export Citation Format

Share Document